^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2

Published date:
02/26/2020
Excerpt:
...we identified BQ323636.1 (BQ), a novel splice variant of nuclear co-repressor NCOR2...BQ was overexpressed in epirubicin-resistant cells and demonstrated that BQ overexpression could reduce the levels of epirubicin-induced ROS and confer epirubicin resistance. In vivo analysis using tissue microarray of primary breast cancer showed direct correlation between BQ expression and chemoresistance.
DOI:
10.3390/cancers12030533